Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RIGL
Stock Latest News
Ratings
Pantginis Reiterates Buy on Rigel, Citing Strengthening Oncology Portfolio and Unchanged $57 Price Target
2d ago
RIGL
Premium
The Fly
Rigel partner Kissei submits new drug application for olutasidenib in Japan
8d ago
RIGL
Premium
The Fly
H.C. Wainwright highlights Rezlidhia NDA as expanding Rigel’s ex-U.S. reach
8d ago
RIGL
Premium
Company Announcements
Lilly and Rigel Advance RA Pipeline as Key LY3871801 Mid-Stage Trial Reaches Completion
13d ago
LLY
RIGL
Premium
Ratings
Rigel: Buy Rating Reiterated as New Oncology Data Support Franchise Strength and Unchanged $57 Price Target
13d ago
RIGL
Premium
Company Announcements
Rigel Shareholders Approve Equity Plans and Board Slate
14d ago
8K
RIGL
Premium
Company Announcements
Rigel Pharmaceuticals Highlights Growth Amid Rising Costs
15d ago
RIGL
Premium
The Fly
Arvinas price target raised to $16 from $14 at BofA
21d ago
PFE
ARVN
Premium
The Fly
Arvinas price target raised to $18 from $16 at BTIG
22d ago
ARVN
RIGL
Premium
The Fly
Rigel Pharmaceuticals price target raised to $81 from $69 at Citi
22d ago
RIGL
Premium
Company Announcements
Rigel Secures Global Rights to VEPPANU Breast Cancer Therapy
22d ago
8K
RIGL
Premium
The Fly
H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’
22d ago
PFE
ARVN
Premium
Ratings
Analyst Reiterates Buy on Rigel as VEPPANU Acquisition Expands Portfolio; Price Target Maintained at $57
23d ago
RIGL
Premium
The Fly
Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu
23d ago
PFE
ARVN
Premium
The Fly
Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer
23d ago
PFE
ARVN
Premium
The Fly
Rigel Pharmaceuticals price target lowered to $69 from $71 at Citi
28d ago
RIGL
Premium
Company Announcements
Rigel Pharmaceuticals Signals Profitable Growth After Earnings Call
28d ago
RIGL
Premium
The Fly
Rigel Pharmaceuticals reports Q1 EPS 44c, consensus 87c
29d ago
RIGL
Premium
The Fly
Rigel Pharma reaffirms FY26 revenue view $275M-$290M, consensus $284.07M
29d ago
RIGL
Premium
Pre-Earnings
Is RIGL a Buy, Before Earnings?
1M ago
RIGL
Premium
Ratings
Rigel: Core Growth Thesis Intact Despite Eli Lilly’s R552 Exit, With Commercial Portfolio and R289 Pipeline Driving Buy Rating
1M ago
RIGL
Premium
Company Announcements
Rigel Regains Rights as Eli Lilly Ends Collaboration
1M ago
8K
RIGL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
